Bone marrow-derived mesenchymal stem cell therapy for decompensated liver cirrhosis: A meta-analysis

World Journal of Gastroenterology

Volumn 20, Issue 38, 2014, Pages 14051-14057

  Pan, Xing Nan ^a   Zheng, Lian Qiu ^a   Lai, Xiao Huan ^a  

^a Clinical Liver Center 180th Hospital of the People's Liberation Army   (China)

Author keywords

Bone marrow stem cell; Decompensated liver cirrhosis; Meta analysis; Transfusion

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; BILIRUBIN;

ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CLINICAL EFFECTIVENESS; DECOMPENSATED LIVER CIRRHOSIS; FOLLOW UP; HUMAN; LIVER FUNCTION; LIVER WEIGHT; MESENCHYMAL STEM CELL TRANSPLANTATION; META ANALYSIS; MODEL FOR END STAGE LIVER DISEASE SCORE; NONHUMAN; PATIENT SAFETY; SURVIVAL; TREATMENT OUTCOME; TREATMENT RESPONSE; ADVERSE EFFECTS; BONE MARROW TRANSPLANTATION; CHI SQUARE DISTRIBUTION; CONVALESCENCE; END STAGE LIVER DISEASE; LIVER CIRRHOSIS; LIVER FUNCTION TEST; PATHOPHYSIOLOGY; PREDICTIVE VALUE; RISK; RISK FACTOR; TIME;

BONE MARROW TRANSPLANTATION; CHI-SQUARE DISTRIBUTION; END STAGE LIVER DISEASE; HUMANS; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MESENCHYMAL STEM CELL TRANSPLANTATION; ODDS RATIO; PREDICTIVE VALUE OF TESTS; RECOVERY OF FUNCTION; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84910011527     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i38.14051     Document Type: Article

References (26)

1. Lee WM. Hepatitis B virus infection. N Engl J Med 1997; 337: 1733-1745 [PMID: 9392700 DOI: 10.1056/NEJM199712113372406]
2. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005; 115: 209-218 [PMID: 15690074 DOI: 10.1172/JCI24282]
3. Lee DS, Gil WH, Lee HH, Lee KW, Lee SK, Kim SJ, Choi SH, Heo JS, Hyon WS, Kim GS, Paik SW, Koh KC, Joh JW. Factors affecting graft survival after living donor liver transplantation. Transplant Proc 2004; 36: 2255-2256 [PMID: 15561210 DOI: 10.1016/j.transproceed.2004.08.073]
4. Dai LJ, Li HY, Guan LX, Ritchie G, Zhou JX. The therapeutic potential of bone marrow-derived mesenchymal stem cells on hepatic cirrhosis. Stem Cell Res 2009; 2: 16-25 [PMID: 19383405 DOI: 10.1016/j.scr.2008.07.005]
5. Terai S, Takami T, Yamamoto N, Fujisawa K, Ishikawa T, Urata Y, Tanimoto H, Iwamoto T, Mizunaga Y, Matsuda T, Oono T, Marumoto M, Burganova G, Fernando Quintanilha L, Hidaka I, Marumoto Y, Saeki I, Uchida K, Yamasaki T, Tani K, Taura Y, Fujii Y, Nishina H, Okita K, Sakaida I. Status and prospects of liver cirrhosis treatment by using bone marrow-derived cells and mesenchymal cells. Tissue Eng Part B Rev 2014; 20: 206-210 [PMID: 24450831 DOI: 10.1089/ten.TEB.2013.0527]
6. Hang HL, Xia Q. Role of BMSCs in liver regeneration and metastasis after hepatectomy. World J Gastroenterol 2014; 20: 126-132 [PMID: 24415865 DOI: 10.3748/wjg.v20.i1.126]
7. Lee JH, Park HJ, Jang IK, Kim HE, Lee DH, Park JK, Lee SK, Yoon HH. In vitro differentiation of human liver-derived stem cells with mesenchymal characteristics into immature hepatocyte-like cells. Transplant Proc 2014; 46: 1633-1637 [PMID: 24935339 DOI: 10.1016/j.transproceed.2013.12.070]
8. Petersen BE, Bowen WC, Patrene KD, Mars WM, Sullivan AK, Murase N, Boggs SS, Greenberger JS, Goff JP. Bone marrow as a potential source of hepatic oval cells. Science 1999; 284: 1168-1170 [PMID: 10325227]
9. Sakaida I, Terai S, Yamamoto N, Aoyama K, Ishikawa T, Nishina H, Okita K. Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice. Hepatology 2004; 40: 1304-1311 [PMID: 15565662 DOI: 10.1002/hep.20452]
10. Terai S, Ishikawa T, Omori K, Aoyama K, Marumoto Y, Urata Y, Yokoyama Y, Uchida K, Yamasaki T, Fujii Y, Okita K, Sakaida I. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells 2006; 24: 2292-2298 [PMID: 16778155 DOI: 10.1634/stemcells.2005-0542]
11. Kamiya A, Inagaki Y. Stem and progenitor cell systems in liver development and regeneration. Hepatol Res 2014 Apr 28; Epub ahead of print [PMID: 24773763 DOI: 10.1111/hepr.12349]
12. Liao X, AnCheng JY, Zhou QJ, Liao C. Therapeutic effect of autologous bone marrow-derived liver stem cells transplantation in hepatitis B virus-induced liver cirrhosis. Hepatogastroenterology 2013; 60: 406-409 [PMID: 23178469 DOI: 10.5754/hge12821]
13. Zhao W, Li JJ, Cao DY, Li X, Zhang LY, He Y, Yue SQ, Wang DS, Dou KF. Intravenous injection of mesenchymal stem cells is effective in treating liver fibrosis. World J Gastroenterol 2012; 18: 1048-1058 [PMID: 22416179 DOI: 10.3748/wjg.v18.i10.1048]
14. Li J, Zhang L, Xin J, Jiang L, Li J, Zhang T, Jin L, Li J, Zhou P, Hao S, Cao H, Li L. Immediate intraportal transplantation of human bone marrow mesenchymal stem cells prevents death from fulminant hepatic failure in pigs. Hepatology 2012; 56: 1044-1052 [PMID: 22422600 DOI: 10.1002/hep.25722]
15. Zheng L, Chu J, Shi Y, Zhou X, Tan L, Li Q, Cui L, Han Z, Han Y, Fan D. Bone marrow-derived stem cells ameliorate hepatic fibrosis by down-regulating interleukin-17. Cell Biosci 2013; 3: 46 [PMID: 24314294 DOI: 10.1186/2045-3701-3-46]
16. Shao CH, Chen SL, Dong TF, Chai H, Yu Y, Deng L, Wang Y, Cheng F. Transplantation of bone marrow-derived mesenchymal stem cells after regional hepatic irradiation ameliorates thioacetamide-induced liver fibrosis in rats. J Surg Res 2014; 186: 408-416 [PMID: 24071025 DOI: 10.1016/j.jss.2013.08.016]
17. Yuan SF, Jiang T, Sun LH, Zheng RJ, Cao GQ, Ahat NZ, Zhang YX. Use of bone mesenchymal stem cells to treat rats with acute liver failure. Genet Mol Res 2014; 13: 6962-6980 [PMID: 24841910 DOI: 10.4238/2014.April.30.10]
18. Amer ME, El-Sayed SZ, El-Kheir WA, Gabr H, Gomaa AA, El-Noomani N, Hegazy M. Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cells. Eur J Gastroenterol Hepatol 2011; 23: 936-941 [PMID: 21900788 DOI: 10.1097/MEG.0b013e3283488b00]
19. Peng L, Xie DY, Lin BL, Liu J, Zhu HP, Xie C, Zheng YB, Gao ZL. Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short-term and long-term outcomes. Hepatology 2011; 54: 820-828 [PMID: 21608000 DOI: 10.1002/hep.24434]
20. Mohamadnejad M, Alimoghaddam K, Mohyeddin-Bonab M, Bagheri M, Bashtar M, Ghanaati H, Baharvand H, Ghavamzadeh A, Malekzadeh R. Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis. Arch Iran Med 2007; 10: 459-466 [PMID: 17903050]
21. Mohamadnejad M, Namiri M, Bagheri M, Hashemi SM, Ghanaati H, Zare Mehrjardi N, Kazemi Ashtiani S, Malekzadeh R, Baharvand H. Phase 1 human trial of autologous bone marrow-hematopoietic stem cell transplantation in patients with decompensated cirrhosis. World J Gastroenterol 2007; 13: 3359-3363 [PMID: 17659676]
22. Lyra AC, Soares MB, da Silva LF, Fortes MF, Silva AG, Mota AC, Oliveira SA, Braga EL, de Carvalho WA, Genser B, dos Santos RR, Lyra LG. Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver disease. World J Gastroenterol 2007; 13: 1067-1073 [PMID: 17373741]
23. Maeda M, Takami T, Terai S, Sakaida I. Autologous bone marrow cell infusions suppress tumor initiation in hepatocarcinogenic mice with liver cirrhosis. J Gastroenterol Hepatol 2012; 27 Suppl 2: 104-111 [PMID: 22320927 DOI: 10.1111/j.1440-1746.2011.07016.x]
24. Wu XZ, Chen D. Helicobacter pylori and hepatocellular carcinoma: correlated or uncorrelated? J Gastroenterol Hepatol 2006; 21: 345-347 [PMID: 16509857 DOI: 10.1111/j.1440-1746.2006.04245.x]
25. Lyra AC, Soares MB, da Silva LF, Braga EL, Oliveira SA, Fortes MF, Silva AG, Brustolim D, Genser B, Dos Santos RR, Lyra LG. Infusion of autologous bone marrow mononuclear cells through hepatic artery results in a short-term improvement of liver function in patients with chronic liver disease: a pilot randomized controlled study. Eur J Gastroenterol Hepatol 2010; 22: 33-42 [PMID: 19654548 DOI: 10.1097/MEG.0b013e32832eb69a]
26. Kharaziha P, Hellström PM, Noorinayer B, Farzaneh F, Aghajani K, Jafari F, Telkabadi M, Atashi A, Honardoost M, Zali MR, Soleimani M. Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial. Eur J Gastroenterol Hepatol 2009; 21: 1199-1205 [PMID: 19455046 DOI: 10.1097/MEG.0b013e32832a1f6c]